Risk Factors and Prognostic Implications of New-Onset Paroxysmal Atrial Fibrillation in Patients Hospitalized with Intracerebral Hemorrhage
暂无分享,去创建一个
[1] J. Cleland,et al. Criteria for Iron Deficiency in Patients With Heart Failure. , 2022, Journal of the American College of Cardiology.
[2] R. Wachter,et al. Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial , 2021, Circulation.
[3] P. Kirchhof,et al. Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study , 2021, The Lancet Neurology.
[4] Mark D. Huffman,et al. Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China , 2021, Heart.
[5] Jeroen J. Bax,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.
[6] R. Helbok,et al. Early Predictors for Infectious Complications in Patients With Spontaneous Intracerebral Hemorrhage and Their Impact on Outcome , 2019, Front. Neurol..
[7] R. Delgado-Mederos,et al. Insular damage, new‐onset atrial fibrillation and outcome after acute intracerebral hemorrhage , 2018, European journal of neurology.
[8] S. Gosselin,et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. , 2018, CJEM.
[9] L. Fauchier,et al. Prediction of Incident Atrial Fibrillation According to Gender in Patients With Ischemic Stroke From a Nationwide Cohort. , 2017, American Journal of Cardiology.
[10] C. Israel,et al. Detection of atrial fibrillation in patients with embolic stroke of undetermined source by prolonged monitoring with implantable loop recorders , 2017, Thrombosis and Haemostasis.
[11] Klaus Gröschel,et al. Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial , 2017, The Lancet Neurology.
[12] D. Hanley,et al. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial , 2017, The Lancet.
[13] Seung‐Jung Park,et al. Predictors and long-term clinical outcomes of newly developed atrial fibrillation in patients with cardiac implantable electronic devices , 2016, Medicine.
[14] D. McManus,et al. Atrial Fibrillation Is Associated With a Worse 90-Day Outcome Than Other Cardioembolic Stroke Subtypes , 2016, Stroke.
[15] Vincenzo Di Lazzaro,et al. Predictors for atrial fibrillation detection after cryptogenic stroke , 2016, Neurology.
[16] Young-Soo Lee. Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the EMBRACE trial. , 2015 .
[17] Yenn-Jiang Lin,et al. Inflammation and the pathogenesis of atrial fibrillation , 2015, Nature Reviews Cardiology.
[18] David J. Gladstone,et al. Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke: Results From the EMBRACE Trial , 2015, Stroke.
[19] Mårten Rosenqvist,et al. High Prevalence of Atrial Fibrillation Among Patients With Ischemic Stroke , 2014, Stroke.
[20] M. Kaste,et al. In-Hospital Cardiac Complications after Intracerebral Hemorrhage , 2014, International journal of stroke : official journal of the International Stroke Society.
[21] Frank Beckers,et al. Cryptogenic stroke and underlying atrial fibrillation. , 2014, The New England journal of medicine.
[22] David J Gladstone,et al. Atrial fibrillation in patients with cryptogenic stroke. , 2014, The New England journal of medicine.
[23] Ana Catarina Fonseca,et al. N-Terminal Pro-Brain Natriuretic Peptide Shows Diagnostic Accuracy for Detecting Atrial Fibrillation in Cryptogenic Stroke Patients , 2014, International journal of stroke : official journal of the International Stroke Society.
[24] W. Hacke,et al. Prevalence of atrial fibrillation in intracerebral hemorrhage , 2014, European journal of neurology.
[25] R. Keep,et al. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets , 2012, The Lancet Neurology.
[26] R. Wachter,et al. Natriuretic Peptides for the Detection of Paroxysmal Atrial Fibrillation in Patients with Cerebral Ischemia – the Find-AF Study , 2012, PloS one.
[27] T. Steiner,et al. Autonomic Effects of Intraventricular Extension in Intracerebral Hemorrhage , 2012, Neurocritical Care.
[28] Jian Wang,et al. Preclinical and clinical research on inflammation after intracerebral hemorrhage , 2010, Progress in Neurobiology.
[29] A. Camm,et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, European heart journal.
[30] D. Levy,et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study , 2009, The Lancet.
[31] A. Rupp,et al. Impaired baroreflex sensitivity predicts outcome of acute intracerebral hemorrhage , 2008, Critical care medicine.
[32] Hongmei Li,et al. Neural Mechanisms of Paroxysmal Atrial Fibrillation and Paroxysmal Atrial Tachycardia in Ambulatory Canines , 2008, Circulation.
[33] Jian Wang,et al. Inflammation after Intracerebral Hemorrhage , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[34] S. Avikainen,et al. Long term survival after primary intracerebral haemorrhage: a retrospective population based study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[35] David Amar,et al. Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation. , 2003, Journal of the American College of Cardiology.
[36] Keishi Kubo,et al. Role of Autonomic Tone in the Initiation and Termination of Paroxysmal Atrial Fibrillation in Patients Without Structural Heart Disease , 2003, Journal of cardiovascular electrophysiology.
[37] Hendrik Bonnemeier,et al. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. , 2003, Circulation.
[38] A. Demchuk,et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy , 2000, The Lancet.
[39] G. Kay,et al. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. , 1997, Journal of the American College of Cardiology.
[40] T Brott,et al. The ABCs of measuring intracerebral hemorrhage volumes. , 1996, Stroke.
[41] J. Broderick,et al. Volume of Intracerebral Hemorrhage: A Powerful and Easy‐to‐Use Predictor of 30‐Day Mortality , 1993, Stroke.
[42] P. O’Neill,et al. Return of atrial mechanical function following electrical conversion of atrial dysrhythmias. , 1990, American heart journal.
[43] R Slama,et al. [The atrial arrhythmia syndrome of vagal origin]. , 1978, Archives des maladies du coeur et des vaisseaux.
[44] KjellAsplund,et al. High Prevalence of Atrial Fibrillation Among Patients With Ischemic Stroke , 2014 .
[45] R. Keep,et al. Blood-brain barrier function in intracerebral hemorrhage. , 2008, Acta neurochirurgica. Supplement.
[46] A. Demchuk,et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. , 2000, Lancet.